XYL Financials Xylem

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Oct 30, 2026, 11:15 UTC Overview →

Growth & profitability

Revenue has grown 14.8% per year over the past 5 years.
Net income has grown faster than revenue (30.4% vs 14.8% per year).
Free cash flow has grown 7.3% per year over the past 5 years.

Financial health

Total debt ($1.9B) exceeds cash ($1.5B); net debt is $463M.
Total debt has grown slower than revenue (-8.8% vs 14.8% per year).
Operating income covered interest expense 42× in the latest year.
Total debt is 1.1× EBITDA.

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 40.9% of earnings and 43.0% of free cash flow.
The dividend has grown 15.8% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2025	$9.0B	$957M	38.5%	13.5%	8.3%	5.4%	$910M	$1.9B	$1.5B
2024	$8.6B	$890M	37.5%	11.8%	8.4%	5.4%	$942M	$2.0B	$1.1B
2023	$7.4B	$609M	36.9%	8.9%	6.0%	3.8%	$566M	$2.3B	$1.0B
2022	$5.5B	$355M	37.7%	11.3%	10.2%	4.5%	$388M	$1.9B	$944M
2021	$5.2B	$427M	38.0%	11.3%	13.3%	5.2%	$330M	$2.4B	$1.3B
2020	—	$254M	—	—	8.6%	2.9%	$641M	$3.1B	$1.9B
2019	—	$401M	—	—	13.6%	5.2%	$613M	$2.3B	$724M
2018	—	$549M	—	—	19.8%	7.6%	$349M	$2.3B	$296M
2017	—	$331M	—	—	13.2%	4.8%	$516M	$2.2B	$414M
2016	—	$260M	—	—	11.9%	4.0%	$373M	$2.4B	$308M
2015	—	$340M	—	—	16.3%	7.3%	$347M	$1.3B	$680M
2014	—	$337M	—	—	15.8%	7.0%	$297M	$1.3B	$663M
2013	—	$228M	—	—	10.2%	4.7%	$198M	$1.2B	$533M
2012	—	$297M	—	—	14.3%	6.3%	$284M	$1.2B	$504M
2011	—	$279M	—	—	15.2%	6.3%	$323M	$1.2B	$318M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Sep '26	$2.2B	$291M	41.2%	17.5%	2.8%	1.7%	$242M	$2.9B	$708M
Jun '26	$2.3B	$263M	41.2%	16.7%	2.5%	1.5%	$201M	$2.9B	$1.3B
Mar '26	$2.1B	$193M	37.8%	11.5%	1.8%	1.1%	$18M	$1.9B	$808M
Dec '25	$2.4B	$335M	38.9%	14.7%	2.9%	1.9%	$460M	$1.9B	$1.5B
Sep '25	$2.3B	$227M	38.9%	14.7%	2.0%	1.3%	$281M	$2.0B	$1.2B
Jun '25	$2.3B	$226M	38.8%	13.3%	2.0%	1.3%	$207M	$2.0B	$1.2B
Mar '25	$2.1B	$169M	37.1%	11.2%	1.6%	1.0%	-$38M	$2.0B	$1.1B
Dec '24	$2.3B	$326M	38.0%	11.8%	3.1%	2.0%	$475M	$2.0B	$1.1B
Sep '24	$2.1B	$217M	37.3%	13.3%	2.0%	1.4%	$237M	$2.0B	$989M
Jun '24	$2.2B	$194M	37.8%	11.7%	1.9%	1.2%	$215M	$2.0B	$815M
Mar '24	$2.0B	$153M	37.0%	10.3%	1.5%	1.0%	$15M	$2.3B	$947M
Dec '23	$2.1B	$266M	35.7%	10.0%	2.6%	1.7%	$361M	$2.3B	$1.0B
Sep '23	$2.1B	$152M	36.8%	9.2%	1.5%	1.0%	$299M	$2.3B	$705M
Jun '23	$1.7B	$92M	37.8%	6.9%	0.9%	0.6%	-$25M	$2.5B	$708M
Mar '23	$1.4B	$99M	37.7%	9.0%	2.8%	1.2%	-$68M	$1.9B	$837M
Dec '22	$1.5B	$149M	38.0%	13.1%	4.3%	1.9%	$302M	$1.9B	$944M
Sep '22	$1.4B	$12M	38.0%	12.2%	0.4%	0.1%	$149M	$2.4B	$1.2B
Jun '22	—	$112M	—	—	3.5%	1.4%	$67M	$2.4B	$1.1B
Mar '22	—	$82M	—	—	2.6%	1.0%	-$130M	$2.4B	$1.1B
Dec '21	—	$113M	—	—	3.5%	1.4%	$139M	$2.4B	$1.3B

Valuation over time

How the market has priced XYL against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has fallen from 67.6× (Mar '23) to 23.3× (Nov '26).
The price-to-sales ratio has fallen from 4.3× (Mar '23) to 2.5× (Nov '26).
The dividend yield has risen from 0.9% (Mar '23) to 1.8% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is XYL growing its revenue and profit?

Over the past 5 years, Xylem's revenue has grown 14.8% per year, and net income grown 30.4% per year. These are computed facts, not advice.

How much debt does XYL have?

As of FY2025, Xylem reported $1.9B of total debt against $1.5B of cash; operating income covered interest expense 42×.

What is XYL's profit margin?

In FY2025, gross margin was 38.5%, operating margin 13.5%, and net margin 10.6%.

What is XYL's P/E ratio?

Xylem's P/E (TTM) is 20.61 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the XYL stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 23.3× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.